CA2604787A1 — Quinobenzoxazine analogs and methods of using thereof
Assigned to Cylene Pharmaceuticals Inc · Expires 2006-10-26 · 20y expired
What this patent protects
The present invention relates to quinobenzoxazines analogs having the general formula: (I)and pharmaceutically acceptable salts, esters and prodrugs thereof; wherein A, U, W, X, Z, B, L, R1, R3, R4 and R5 are substituents.The present invention also relates to methods for using su…
USPTO Abstract
The present invention relates to quinobenzoxazines analogs having the general formula: (I)and pharmaceutically acceptable salts, esters and prodrugs thereof; wherein A, U, W, X, Z, B, L, R1, R3, R4 and R5 are substituents.The present invention also relates to methods for using such compounds.
Drugs covered by this patent
- Retevmo (SELPERCATINIB) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.